The Traderszone Network

Published in TZ Latest News 8 August, 2016 by The TZ Newswire Staff

Allergan’s Q2 Earnings Beat Boosted by Botox

With the failed Pfizer merger out of the way, Allergan appears focused and is looking once again to maximize growth in its cores business.